Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_assertion type Assertion NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_head.
- NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_assertion description "[Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_provenance.
- NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_assertion evidence source_evidence_literature NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_provenance.
- NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_assertion SIO_000772 24607843 NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_provenance.
- NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_assertion wasDerivedFrom befree-2016 NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_provenance.
- NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_assertion wasGeneratedBy ECO_0000203 NP1161700.RA2IrbS6dpuu2uRGmzYdghPWYXoczI8yEAHr0Qml4_w34130_provenance.